Citations (22)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Eylem Eliacik, Ayse Isik, Cisel Aydin, Aysegul Uner, Salih Aksu, Nilgun Sayinalp, Haluk Demiroglu, Hakan Goker, Yahya Buyukasik, Osman Ozcebe & Ibrahim C. Haznedaroglu. (2015) Bone marrow fibrosis may be an effective independent predictor of the ‘TKI drug response level’ in chronic myeloid leukemia. Hematology 20:7, pages 392-396.
Read now
Read now
Peter Valent, Wolfgang R Sperr, Karl Sotlar, Andreas Reiter, Cem Akin, Jason Gotlib, Hans-Peter Horny & Michel Arock. (2014) The serum tryptase test: an emerging robust biomarker in clinical hematology. Expert Review of Hematology 7:5, pages 683-690.
Read now
Read now
Anja Förster, Franco H. Falcone, Bernhard F. Gibbs, Liane M. Preussner, Britta S. Fiebig, Hülya Altunok, Jens M. Seeger, Sabine Cerny-Reiterer, Anja Rabenhorst, Kerstin Papenfuss, Peter Valent, Hamid Kashkar & Karin Hartmann. (2013) Anti-Fas/CD95 and tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) differentially regulate apoptosis in normal and neoplastic human basophils. Leukemia & Lymphoma 54:4, pages 835-842.
Read now
Read now
Satoko Oka, Kazuo Muroi, Masaki Mori, Tomohiro Matsuyama, Shin-Ichiro Fujiwara, Iekuni Oh, Kazuya Sato, Satoru Kikuchi, Masuzu Ueda, Masaki Toshima, Takahiro Suzuki, Katsutoshi Ozaki, Tadashi Nagai & Keiya Ozawa. (2009) Prediction of response to imatinib in patients with chronic myelogenous leukemia by flow cytometric analysis of bone marrow blastic cell phenotypes. Leukemia & Lymphoma 50:2, pages 290-293.
Read now
Read now
Articles from other publishers (18)
Irina Sadovnik, Daniel Ivanov, Dubravka Smiljkovic, Gabriele Stefanzl, Lina Degenfeld-Schonburg, Susanne Herndlhofer, Gregor Eisenwort, Alexander W. Hauswirth, Thamer Sliwa, Felix Keil, Wolfgang R. Sperr & Peter Valent. (2022) Identification of CD203c as a New Basophil-Specific Flow-Marker in Ph+ Chronic Myeloid Leukemia. Cells 12:1, pages 3.
Crossref
Crossref
Claudio Ortolani. 2021. Flow Cytometry of Hematological Malignancies. Flow Cytometry of Hematological Malignancies
301
427
.
Giovanni Paolino, Paola Corsetti, Elisa Moliterni, Serena Corsetti, Dario Didona, Marcello Albanesi, Carlo Mattozzi, Paolo Lido & Stefano Calvieri. (2019) Mast cells and cancer. Giornale Italiano di Dermatologia e Venereologia 154:6.
Crossref
Crossref
Barbara J. Bain, David M. Clark & Bridget S. Wilkins. 2019. Bone Marrow Pathology. Bone Marrow Pathology
267
345
.
Peter Valent, Hans-Peter Horny & Michel Arock. (2018)
The underestimated role of basophils in Ph
+
chronic myeloid leukaemia
. European Journal of Clinical Investigation 48:10, pages e13000.
Crossref
Crossref
Laura Sánchez-Muñoz, Jose M. Morgado, Ivan Álvarez-Twose, Almudena Matito, Andrés C. Garcia-Montero, Cristina Teodosio, Maria Jara-Acevedo, Andrea Mayado, Manuela Mollejo, Carolina Caldas, David González de Olano, Luis Escribano & Alberto Orfao. (2016)
Diagnosis and classification of mastocytosis in non-specialized
versus
reference centres: a Spanish Network on Mastocytosis (REMA) study on 122 patients
. British Journal of Haematology 172:1, pages 56-63.
Crossref
Crossref
A. Matito, I. Alvarez-Twose, J. M. Morgado, L. Sánchez-Muñoz, A. Orfao & L. Escribano. (2014) Anaphylaxis as a Clinical Manifestation of Clonal Mast Cell Disorders. Current Allergy and Asthma Reports 14:8.
Crossref
Crossref
Elisa Nigro, Antonio Siccardi & Luca Vangelista. (2013) Role and Redirection of IgE against Cancer. Antibodies 2:4, pages 371-391.
Crossref
Crossref
Luis Escribano, Andrés Garcia‐Montero, Laura Sanchez‐Muñoz, Cristina Teodosio, Ivan Alvarez‐Twose, Maria Jara‐Acevedo, José Mario Morgado, Julia Almeida & Alberto Orfao. 2012. Laboratory Hematology Practice. Laboratory Hematology Practice
388
398
.
Claudio Ortolani. 2011. Flow Cytometry of Hematological Malignancies. Flow Cytometry of Hematological Malignancies
160
300
.
Laura Sánchez-Muñoz, Cristina Teodósio, José M. Morgado & Luis Escribano. 2011. Recent Advances in Cytometry, Part B - Advances in Applications. Recent Advances in Cytometry, Part B - Advances in Applications
333
359
.
Peter Valent. (2010) Standard treatment of Ph+ CML in 2010: how, when and where not to use what BCR/ABL1 kinase inhibitor?. European Journal of Clinical Investigation 40:10, pages 918-931.
Crossref
Crossref
Peter Valent. (2010) Management of Chronic Myeloid Leukemia with BCR/ABL Inhibitors: Current Status and Future Perspectives. Clinical Medicine Insights: Therapeutics 2, pages CMT.S2439.
Crossref
Crossref
Sophia N. Karagiannis, Frank O. Nestle & Hannah J. Gould. 2010. Cancer and IgE. Cancer and IgE
185
213
.
Barbara J. Bain, David M. Clark & Bridget S. Wilkins. 2009. Bone Marrow Pathology. Bone Marrow Pathology
239
299
.
Bridget S Wilkins & David M Clark. (2009) Making the most of bone marrow trephine biopsy. Histopathology 55:6, pages 631-640.
Crossref
Crossref
. (2008) Current Awareness in Hematological Oncology. Hematological Oncology 26:4, pages 253-260.
Crossref
Crossref
Peter Valent, Thomas Lion, Dominik Wolf, Christian Sillaber, Hermine Agis, Andreas Petzer, Alois Lang, Peter Kalhs, Dietmar Geissler, Richard Greil, Werner Linkesch, Sonja Burgstaller, Josef Thaler & Günther Gastl. (2008) Diagnostic algorithms, monitoring, prognostication, and therapy in chronic myeloid leukemia (CML): a proposal of the Austrian CML platformDiagnostische Algorithmen, Prognose und Therapie in der Chronisch Myeloischen Leukämie (CML): Ein Proposal der Österreichischen CML-Plattform. Wiener klinische Wochenschrift 120:21-22, pages 697-709.
Crossref
Crossref